Sports participation and physical activity in patients with von Willebrand disease by Atiq, F. (Ferdows) et al.
Haemophilia. 2018;1–8.	 	 	 | 	1wileyonlinelibrary.com/journal/hae
 
Received:	29	June	2018  |  Revised:	10	September	2018  |  Accepted:	9	October	2018
DOI:	10.1111/hae.13629
O R I G I N A L  A R T I C L E
Sports participation and physical activity in patients with von 
Willebrand disease
Ferdows Atiq1  | Eveline P. Mauser‐Bunschoten2 | Jeroen Eikenboom3,4  |  
Karin P. M. van Galen2  | Karina Meijer5  | Joke de Meris6 | Marjon H. Cnossen7  |  
Erick A. M. Beckers8 | Britta A. P. Laros‐van Gorkom9 | Laurens Nieuwenhuizen10  |  
Johanna G. van der Bom11,12  | Karin Fijnvandraat13  | Frank W. G. Leebeek1  |  
for the WiN study group
1Department	of	Hematology,	Erasmus	University	Medical	Center,	Rotterdam,	The	Netherlands
2Van	Creveldkliniek,	University	Medical	Center	Utrecht,	Utrecht	University,	Utrecht,	The	Netherlands
3Department	of	Internal	Medicine,	Division	of	Thrombosis	and	Hemostasis,	Leiden	University	Medical	Center,	Leiden,	The	Netherlands
4Einthoven	Laboratory	for	Vascular	and	Regenerative	Medicine,	Leiden	University	Medical	Center,	Leiden,	The	Netherlands
5Department	of	Hematology,	University	of	Groningen,	University	Medical	Center	Groningen,	Groningen,	The	Netherlands
6Netherlands	Hemophilia	Patient	Society,	Leiden,	The	Netherlands
7Department	of	Pediatric	Hematology,	Erasmus	University	Medical	Center,	Sophia	Children’s	Hospital,	Rotterdam,	The	Netherlands
8Department	of	Internal	Medicine,	Maastricht	University	Medical	Center	Plus,	Maastricht,	The	Netherlands
9Department	of	Hematology,	Radboud	university	medical	center,	Nijmegen,	The	Netherlands
10Department	of	Internal	Medicine,	Maxima	Medical	Center,	Eindhoven,	The	Netherlands
11Department	of	Clinical	Epidemiology,	Leiden	University	Medical	Center,	Leiden,	The	Netherlands
12Jon	J	van	Rood	Center	for	Clinical	Transfusion	Medicine,	Sanquin	Research,	Leiden,	The	Netherlands
13Pediatric	Hematology,	Emma	Children’s	Hospital‐Academic	Medical	Center,	Amsterdam,	The	Netherlands
This	is	an	open	access	article	under	the	terms	of	the	Creative	Commons	Attribution‐NonCommercial‐NoDerivs	License,	which	permits	use	and	distribution	in	
any	medium,	provided	the	original	work	is	properly	cited,	the	use	is	non‐commercial	and	no	modifications	or	adaptations	are	made.
©	2018	The	Authors.	Haemophilia	Published	by	John	Wiley	&	Sons	Ltd
The	WiN	study	group	present	in	AppendixS1	in	Supporting	Information.
Correspondence
Frank	W.	G.	Leebeek,	Department	of	
Hematology,	Erasmus	University	Medical	
Center,	Rotterdam,	The	Netherlands.
Email:	f.leebeek@erasmusmc.nl
Funding information
Dutch	Hemophilia	Foundation	(Stichting	
Haemophilia);	CSL	Behring
Introduction:	Patients	with	bleeding	disorders	may	experience	limitations	in	sports	
participation	and	physical	activity.	Several	studies	on	sports	participation	have	been	
performed	in	haemophilia	patients,	but	studies	in	patients	with	von	Willebrand	dis‐
ease	(VWD)	are	lacking.
Aim:	We	assessed	the	sports	participation	and	physical	activity	of	a	large	cohort	of	
VWD	patients.
Methods:	 Patients	were	 included	 from	 the	 “WiN	 study.”	All	 patients	 completed	 a	
questionnaire	on	sports	participation,	physical	activity,	quality	of	 life	and	bleeding	
symptoms	(Tosetto	bleeding	score).
Results:	From	the	798	included	patients,	474	had	type	1,	301	type	2	and	23	type	3	
VWD.	The	mean	age	was	39	±	20	(standard	deviation)	years.	Five	hundred	and	fifty‐
two	patients	(69.3%)	participated	in	various	types	of	sports.	Type	3	VWD	patients	
more	 often	 did	 not	 participate	 in	 sports	 due	 to	 fear	 of	 bleeding	 and	 physical	
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1  | INTRODUC TION
von	Willebrand	disease	(VWD)	is	the	most	common	inherited	bleed‐
ing	 disorder.1	 VWD	 is	 caused	 by	 reduced	 von	 Willebrand	 factor	
(VWF)	 levels	 (type	1),	 an	abnormal	 function	of	VWF	 (type	2)	or	 a	
complete	 absence	 of	VWF	 (type	 3).2,3	 Although	VWD	 is	 clinically	
mainly	characterized	by	mucocutaneous	bleeding,	all	types	of	bleed‐
ing	can	occur.4‐6	We	previously	found	that	adults	and	children	with	
VWD	have	a	lower	health‐related	quality	of	life	(HRQoL)	compared	
to	the	general	population.6‐9	In	adults,	a	more	severe	bleeding	phe‐
notype	was	associated	with	a	lower	HRQoL	on	the	domains	of	phys‐
ical	 functioning,	and	more	often	 led	to	 limitations	due	to	 impaired	
physical	 functioning.7	 This	 is	 especially	 seen	 in	patients	with	 type	
3,	who	 typically	 have	 very	 low	 levels	 of	 FVIII	 and	 therefore	 have	
besides	 mucocutaneous	 bleeds,	 a	 more	 haemophilia‐like	 bleeding	
tendency,	including	joint	and	muscle	bleeds.
Patients	with	VWD	and	other	bleeding	disorders	including	hae‐
mophilia	 are	 in	 several	ways	 limited	 to	 perform	physical	 activities	
and	sports.10	They	may	have	a	higher	risk	of	bleeding	during	physical	
activities	 and/or	 sports,	 especially	 high‐risk	 sports,	 and	 therefore,	
these	patients	may	be	less	inclined	to	participate	in	physical	activ‐
ities	and/or	sports	due	to	fear	for	such	bleeding.11,12	On	the	other	
hand,	patients	with	bleeding	disorders	more	often	have	a	physical	
impairment	due	to	(joint)bleeds	and	arthropathy	and	therefore	could	
have	a	reduced	physical	activity	in	comparison	with	the	general	pop‐
ulation.5,11	It	has	been	previously	shown	that	although	patients	with	
haemophilia	A	and	B	participate	as	frequently	in	sports	as	the	general	
population,	 they	often	participate	 in	different	 types	of	sports.13‐15 
Patients	generally	avoided	sports	with	a	high	risk	of	bleeding,	such	as	
soccer,	as	is	advised	by	the	World	Federation	of	Hemophilia	(WFH)	
and	 the	 American	 National	 Hemophilia	 Foundation	 (NFH).13,16 
Patients	with	haemophilia	more	often	participated	in	swimming	and	
cycling	than	the	general	population.13
It	 is	well	known	that	physical	activity	 is	 important	for	the	gen‐
eral	health,	as	 it	 is	associated	with	great	health	benefits,	such	as	a	
lower	risk	of	cardiovascular	disease,	hypertension,	obesity,	diabetes,	
depression	and	osteoporosis.11	Several	studies	have	been	reported	
on	sports	participation	and	physical	activity	in	haemophilia	patients.	
No	large	studies	have	been	performed	on	sports	participation	and	
physical	activity	in	VWD	patients.
Therefore,	we	aim	to	study	the	sports	participation	and	physi‐
cal	activity	of	a	large	cohort	of	VWD	patients.	Secondly,	we	aim	to	
identify	subgroups	of	VWD	patients	who	experience	difficulties	in	
sports	 participation	 and	 physical	 activity,	 in	 order	 to	 increase	 the	
awareness	for	the	sports	participation	and	physical	activity	of	these	
patients.
2  | MATERIAL S AND METHODS
2.1 | Participants
We	 included	 patients	 who	 participated	 in	 the	 “Willebrand	 in	 the	
Netherlands”	 (WiN)	 study;	 a	 nationwide	 cross‐sectional	 study	 in	
VWD	patients	in	the	Netherlands.	Patients	were	included	between	
2007	and	2009.	The	inclusion	criteria	for	the	WiN	study	were	haem‐
orrhagic	 symptoms	 or	 a	 family	 history	 of	 VWD	 and	 historically	
lowest	VWF:Ag	and/or	VWF:RCo	≤0.30	IU/mL	and/or	FVIII	 levels	
(FVIII:C)	≤0.40	IU/mL	(for	type	2N	VWD).	We	excluded	patients	with	
other	hemostatic	disorders.	Patients	who	were	originally	diagnosed	
with	type	3	VWD	were	based	on	VWF	propeptide	<0.05	IU/mL	clas‐
sified	as	type	3	VWD	(n	=	23),	whereas	patients	with	VWF	propetide	
≥0.05	IU/mL	were	 classified	 as	 type	 1	 VWD	 (n	=	23).17	 The	 study	
was	approved	by	the	Medical	Ethical	Committees	of	all	participating	
centres.	All	patients	signed	informed	consent.
2.2 | Assessment methods
The	 assessment	 methods	 and	 laboratory	 measurements	 have	
been	 described	 in	 detail	 previously.4,7,18	 Participants	 completed	
impairment,	 respectively,	OR	=	13.24	 (95%	CI:	 2.45‐71.53)	 and	OR	=	5.90	 (95%	CI:	
1.77‐19.72).	Patients	who	did	not	participate	in	sports	due	to	physical	impairment	had	
a	 higher	 bleeding	 score	 item	 for	 joint	 bleeds	 1.0	 (±1.6)	 vs	 0.5	 (±	 1.1)	 (P	=	0.036).	
Patients	with	type	3	VWD	and	patients	with	a	higher	bleeding	score	frequently	had	
severe	limitations	during	daily	activities,	respectively,	OR	=	9.84	(95%	CI:	2.83‐34.24)	
and	OR	=	1.08	(95%	CI:	1.04‐1.12).
Conclusion:	The	majority	of	VWD	patients	participated	in	sports.	Patients	with	type	
3	VWD,	a	history	of	joint	bleeds	and	a	more	severe	bleeding	phenotype	frequently	
experienced	 limitations	 in	 sports	 participation	 and	physical	 activities	 during	 daily	
life.
K E Y W O R D S
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an	extensive	questionnaire,	including	questions	on	sports	partici‐
pation,	physical	activity,	the	short	form‐36	(SF‐36)	and	a	self‐ad‐
ministered	version	of	 the	condensed	Tosetto	bleeding	score.19,20 
Patients	 could	 report	 whether	 they	 participated	 in	 sports,	 and	
what	kind	of	sports	they	did.	Patients	who	did	not	participate	 in	
sports	were	additionally	asked	the	reason	why	they	did	not	per‐
form	sports.	For	physical	activity,	patients	could	 report	whether	
they	did	<1,	1‐2,	2‐4	hours	or	more	than	4	hours	of	physical	activ‐
ity	per	week.	Limitations	in	physical	activity,	general	health	status	
and	happiness	were	derived	from	the	SF‐36	questionnaire.	Severe	
limitations	 during	 daily	 activity	were	 defined	 as	 answering	 “yes,	
limited	 a	 lot”	 to	 the	 SF‐36	 question	 on	 whether	 patients	 have	
physical	limitations.
2.3 | Bleeding risk of sports
Patients	were	asked	to	report	the	sports	that	they	performed	in	the	
year	prior	to	study	 inclusion.	To	classify	sports	based	on	their	 risk	
for	 bleeding,	we	 used	 a	modification	 of	 the	 taxonomy	devised	 by	
the	 American	 National	 Hemophilia	 Foundation.21	We	 categorized	
sports	 in	 three	groups	 instead	of	 five	groups,	as	has	been	done	 in	
prior	 studies.22	 In	 Table	 1,	 we	 present	 the	 bleeding	 risk	 category	
of	 some	 common	 sports	 in	 our	 population.	Category	1	 sports	 are	
sports	with	a	 low	risk	of	bleeding	 (such	as	swimming).	Category	2	
sports	are	sports	with	an	intermediate	risk	of	bleeding	(such	as	cy‐
cling).	Category	3	sports	are	sports	with	a	high	risk	of	bleeding	(such	
as	 soccer).	 Patients	 who	 performed	 several	 types	 of	 sports	 were	
categorized	according	to	the	sport	with	the	highest	risk	of	bleeding.
2.4 | Statistical methods
Categorical	 data	 are	 presented	 as	 frequencies	 and	 proportions.	
Continuous	 data	 are	 presented	 as	median	 and	 interquartile	 range	
[IQR]	or	mean	and	(standard	deviation	[SD]).
Physical	 activity,	 sports	 participation	 and	 reasons	 not	 to	 par‐
ticipate	in	sports	were	compared	between	different	types	of	VWD	
using	a	chi‐square	test.	Age	was	compared	between	different	groups	
using	an	independent	sample	t	test	(central	limit	theorem).	Binomial	
outcomes	(sports	vs	no	sport,	high‐risk	sport	vs	no	high‐risk	sport,	
etcetera.)	 were	 adjusted	 for	 age	 and	 sex	 using	 logistic	 regression	
analysis.	The	association	between	sports	participation	and	bleeding	
history,	and	physical	activity	and	bleeding	history	was	only	analysed	
for	the	total	bleeding	score,	the	bleeding	score	item	for	joint	bleeds,	
the	bleeding	score	item	for	muscle	haematoma,	the	bleeding	score	
item	for	cutaneous	bleeding	and	the	bleeding	score	 item	for	men‐
orrhagia.	We	 analysed	 these	 associations	 using	 logistic	 regression	
analysis,	 in	which	we	corrected	 for	age	and	sex.	For	menorrhagia,	
we	only	corrected	for	age.	We	did	not	analyse	other	bleeding	score	
items,	because	it	is	not	biologically	plausible	that	they	are	associated	
with	sports	participation	or	physical	activity.	The	linear	association	
between	physical	activity	and	general	health	status	and	happiness	
was	 investigated	 using	 the	 Mantel‐Haenszel	 test.	 We	 performed	
stepwise	multivariate	logistic	regression	analysis	using	the	Wald	test	
in	a	forward	approach	to	identify	variables	that	were	independently	
associated	with	binomial	outcomes.	The	variables	that	were	included	
in	the	multivariate	 logistic	analysis	were	age,	sex,	BMI	and	type	of	
VWD.
Outcomes	of	logistic	regression	analyses	are	presented	as	odds	
ratio	 (OR)	 followed	by	 the	95%	confidence	 interval	 (CI).	 Statistical	
analyses	were	performed	with	SPSS	 IBM	version	24.0	 (IBM	Corp.,	
Armonk,	NY,	USA).	A	P‐value	below	0.05	was	defined	as	significant.
3  | RESULTS
We	included	798	patients	of	the	total	WiN	study	population	of	837	
patients.	We	excluded	39	patients	due	to	missing	data	on	physical	
activity	and	sports	participation.	Table	2	shows	 the	baseline	char‐
acteristics.	 Patients	 with	 type	 3	 VWD	 were	 younger	 than	 type	
1	 and	 type	 2	VWD	patients,	 respectively,	 29	±	20	 (mean	±	SD)	 vs	
40	±	20	and	38	±	21	years	 (P	=	0.044).	Also,	 type	3	VWD	patients	
had	a	higher	total	bleeding	score	than	patients	with	type	1	and	type	
2	VWD,	respectively,	19	[12‐23]	vs	9	[5‐14]	and	11	[7‐14]	(P	<	0.001;	
Table	2).	Patients	with	type	1	VWD	were	more	often	female	(n	=	306	
(64.6%)	vs	n	=	160	 (53.2%)	 in	 type	2	 and	n	=	13	 (56.5%)	 in	 type	3	
VWD	 (P	=	0.006))	 and	 had	 more	 often	 blood	 group	 O	 (n	=	294	
(68.4%)	 vs	 n	=	131	 (50.4%)	 in	 type	 2	 and	 n	=	7	 (30.4%)	 in	 type	 3	
(P	<	0.001;	Table	2))
3.1 | Sports participation
From	the	total	population,	552	VWD	patients	(69.3%)	participated	
in	 sports	 in	 the	 previous	months	 prior	 to	 inclusion	 in	 the	 study.	
In	 patients	 younger	 than	 18,	 18‐34,	 35‐64	years	 and	 older	 than	
65	years,	 respectively,	 110	 (72.4%),	 131	 (76.6%),	 268	 (66.2%)	
and	 43	 (62.3%)	 participated	 in	 sports.	 There	 was	 no	 difference	
Category Sports
1.	Low	risk Swimming,	walking,	tai	chi,	dancing,	table	tennis,	petanque	(jeu	de	boules),	
golf,	aerobics,	watersports,	steps,	physiotherapy	exercises,	pool/snooker
2.	Intermediate	
risk
Yoga,	cycling,	climbing,	school	physical	exercise	lesson,	running/jogging,	
volleyball,	tennis,	surfing,	squash,	karting,	horse	riding,	skiing	(cross‐coun‐
try),	korfball,	gymnastics,	badminton
3.	High	risk Wrestling,	martial	arts	(except	tai	chi),	boxing,	soccer,	skiing,	(ice)	skating,	
snowboarding,	hockey,	motorsport,	rugby,	racquetball,	mountain	biking
TA B L E  1  Risk	of	sports	for	bleeding
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in	 sports	participation	among	 the	 three	 types	of	VWD	 (Table	2,	
P	=	0.520).
Most	 VWD	 patients	 participated	 in	 cycling	 (42%),	 followed	
by	walking	 (36%)	and	swimming	 (24%;	Figure	1).	Twelve	patients	
participated	in	martial	arts,	such	as	karate	and	kickboxing.	In	the	
total	VWD	study	population,	the	percentage	of	patients	who	par‐
ticipated	 in	 low‐risk,	 intermediate‐risk	 and	 high‐risk	 sports	 was	
respectively	 13.4%,	 66.7%	 and	 19.9%.	 The	 age	 of	 patients	 who	
participated	 in	 low‐risk,	 intermediate‐risk	 and	 high‐risk	 sports	
was	43	±	20,	42	±	19	and	26	±	17	years,	 respectively	 (P	<	0.001),	
indicating	 that	 high‐risk	 sports	 were	 performed	 more	 often	 by	
younger	patients.
Patients	who	participated	in	sports	had	a	higher	bleeding	score	
item	for	muscle	haematoma	0.38	±	0.95	vs	0.24	±	0.75	(P	=	0.023),	
which	 remained	 significant	 after	 correction	 for	 age	 and	 sex	
(OR	=	1.26,	95%	CI:	1.04‐1.53).	In	multivariate	logistic	regression	
analysis,	 BMI	 was	 independently	 associated	 with	 less	 frequent	
participation	 in	 sports	 (Table	3).	Age	 and	 female	 sex	were	 inde‐
pendently	 associated	 with	 less	 participation	 in	 high‐risk	 sports	
(Table	3).
3.2 | Reason not to sport
Two	hundred	and	forty‐six	patients	did	not	participate	 in	sports,	
of	 whom	 175	 reported	 the	 reason	 why	 they	 did	 not	 perform	
sports.	Most	patients	(47.4%)	did	not	sport	due	to	a	lack	of	time,	
while	 27.4%	did	 not	 sport	 due	 to	 lack	 of	motivation,	 26.9%	due	
to	physical	limitations,	6.9%	due	to	fear	of	bleeding	and	8.6%	for	
other	reasons.	Patients	with	fear	of	bleeding	were	older	(56	±	17	
vs	39	±	20	years,	P	=	0.005),	and	had	a	higher	total	bleeding	score	
(17	±	7.0	 vs	 11	±	7.2,	 P	=	0.004),	 than	 other	 VWD	 patients.	 The	
total	bleeding	score	remained	higher	after	correction	for	age	and	
sex	(OR	=	1.08,	95%	CI:	1.00‐1.17).	Multivariate	logistic	regression	
analysis	 revealed	 that	age	and	 type	3	VWD	were	 independently	
associated	 with	 no	 sports	 participation	 due	 to	 fear	 of	 bleeding	
(Table	3).
Type 1 (n = 474) Type 2 (n = 301) Type 3 (n = 23)
Age	(y),	mean	±	SD 40	±	20* 38	±	21* 29	±	20*
Sex,	female	(%) 306	(64.6%)* 160	(53.2%)* 13	(56.5%)*
BMI	(kg/m2),	
mean	±	SD
24	±	5.2 24	±	5.1 23	±	4.1
Blood	groups	O	(%) 294	(68.4%)** 131	(50.4%)** 7	(30.4%)**
VWF	levelsa
VWF:Ag	(IU/mL) 0.37	[0.22‐0.51] 0.24	[0.16‐0.34] 0.00	[0.00‐0.01]
VWF:CB	(IU/mL) 0.41	[0.21‐0.63] 0.08	[0.06‐0.14] 0.00	[0.00‐0.00]
VWF:Act	(IU/mL) 0.43	[0.22‐0.68] 0.08	[0.04‐0.16] 0.00	[0.00‐0.00]
FVIII:C	(IU/mL) 0.65	[0.47‐0.86] 0.36	[0.27‐0.48] 0.02	[0.01‐0.03]
Bleeding	score 9	[5‐14]** 11	[7‐16]** 19	[12‐23]**
Sports	participation,	
number	(%)
334	(70.5%) 204	(68.0%) 14	(60.9%)
Physical	activity	per	week,	number	(%)b
0‐1	h 92	(20.3%) 48	(16.7%) 7	(30.4%)
1‐2	h 112	(24.7%) 76	(26.5%) 4	(17.4%)
2‐4	h 129	(28.4%) 85	(29.6%) 6	(26.1%)
>4 h 121	(26.7%) 78	(27.2%) 6	(26.1%)
Data	presented	as	median	[interquartile	ranges],	unless	otherwise	specified;
aCentrally	measured	at	inclusion.	Measurements	available	in	647	patients.	
bIn	type	1	and	type	2	VWD,	there	were,	respectively,	20	and	14	patients	with	missing	data.	
*P	<	0.05;	**	P	<	0.001	between	types	1,	2	and	3	VWD.	
TA B L E  2  Baseline	characteristics	of	
the	Von	Willebrand	disease	patients
F I G U R E  1  Types	of	sports	performed	by	VWD	patients
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Forty‐seven	patients	did	not	participate	in	sports	due	to	physical	
limitations.	 Patients	with	 physical	 limitations	were	 older	 than	 other	
VWD	patients,	52	±	15	vs	35	±	23	years	(P	<	0.001).	The	proportion	of	
patients	who	did	not	participate	in	sports	due	to	physical	 limitations	
was	higher	in	type	3	VWD	than	in	type	1	and	type	2	VWD,	respectively,	
17.4%	vs	6.1%	and	4.7%	(P	=	0.041).	They	presented	with	a	higher	total	
bleeding	score,	a	higher	bleeding	score	for	the	joint	bleeds	item	and	a	
higher	bleeding	score	 item	for	menorrhagia,	respectively,	15	±	7.3	vs	
11	±	7.2	(P	<	0.001),	1.0	±	1.6	vs	0.5	±	1.1	(P	=	0.036)	and	2.9	±	1.2	vs	
2.2	±	1.5	(P	=	0.003).	After	correction	for	age	and	sex,	total	bleeding	
score	and	bleeding	score	 item	for	 joint	bleeds	remained	significantly	
higher	 in	 patients	 with	 physical	 limitations,	 respectively,	 OR	=	1.05	
(95%	CI:	1.01‐1.09)	and	OR	=	1.31	(95%	CI:	1.07‐1.61).	In	multivariate	
logistic	analysis	age,	BMI	and	type	3	VWD	were	independently	associ‐
ated	with	no	participation	in	sports	due	to	physical	limitations	(Table	3).
3.3 | Physical activity
More	than	a	quarter	of	 the	 total	population	performed	more	than	
4	hours	of	physical	activity	per	week,	whereas	18%	was	active	for	
<1	hour	 per	 week	 (Table	 1).	 Patients	 who	 performed	 more	 than	
4	hours	 of	 physical	 activity	 per	 week	 were	 younger	 compared	 to	
patients	 with	 <4	hours	 of	 physical	 activity	 per	 week,	 36	±	21	 vs	
40	±	19	years	(P	=	0.011).	There	was	no	difference	in	physical	activ‐
ity	per	week	among	 the	 three	 types	of	VWD	 (Table	2;	P	=	0.723).	
There	was	 no	 association	 between	 bleeding	 history	 and	 hours	 of	
physical	activity	 (data	not	shown).	Multivariate	 logistic	analysis	re‐
vealed	that	patients	who	did	more	than	4	hours	of	physical	activity	
per	week	had	a	lower	BMI	(Table	3).
The	 percentage	 of	 patients	 aged	 16	years	 and	 older	 who	 re‐
ported	to	have	severe	 limitations	 in	walking	100,	500	and	1000	m	
were,	respectively,	2.4%,	5.4%	and	8.7%.	Patients	with	type	3	VWD	
had	more	 frequent	 than	other	VWD	patients	 severe	 limitations	 in	
walking	distance:	500	m	OR	=	8.24	(95%	CI:	1.96‐34.62)	and	1000	m	
OR	=	4.31	 (95%	 CI:	 1.07‐17.37),	 both	 corrected	 for	 age	 and	 sex	
(Figure	2).	Furthermore,	bleeding	score	item	for	joint	bleeds	was	as‐
sociated	with	severe	limitations	to	walk	1000	m	(OR	=	1.24,	95%	CI:	
1.01‐1.53,	corrected	for	age	and	sex).	In	multivariate	logistic	analysis	
age,	sex,	BMI	and	type	3	VWD	were	independently	associated	with	
severe	limitations	to	walk	1000	m	(Table	3).
3.4 | Activities during daily life
The	number	of	patients	who	had	severe	limitations	to	lift	or	to	carry	
groceries,	to	climb	up	stairs,	and	to	bow,	to	kneel	or	to	bend	was	re‐
spectively	47	(7.4%),	42	(6.6%)	and	57	patients	(9.0%).	Patients	with	
type	3	VWD	more	often	had	severe	limitations	during	these	daily	
activities	(Figure	2).	After	correction	for	age	and	sex,	patients	with	
type	3	VWD	remained	to	have	more	often	severe	limitations	to	lift	
or	to	carry	groceries	and	to	bow,	to	kneel	or	to	bend,	respectively,	
OR	=	5.80	(95%	CI:	1.37‐24.56)	and	OR	=	9.84	(95%	CI:	2.83‐34.24).
A	 higher	 total	 bleeding	 score	was	 associated	with	 severe	 limita‐
tions	to	climb	up	stairs	and	severe	 limitations	to	bow,	 to	kneel	or	 to	
bend,	respectively,	OR	=	1.07	(95%	CI:	1.03‐1.12)	and	OR	=	1.08	(95%	
CI:	1.04‐1.12),	both	corrected	for	age	and	sex.	The	bleeding	score	item	
for	joint	bleeds	was	also	associated	with	severe	limitations	to	climb	up	
stairs	(OR	=	1.36,	95%	CI:	1.09‐1.69,	corrected	for	age	and	sex).
In	 multivariate	 logistic	 analysis	 age,	 female	 sex	 and	 type	 3	
VWD	were	independently	associated	with	severe	limitations	to	lift	
something	up	or	to	carry	groceries	(Table	3).	Age	and	BMI	were	in‐
dependently	 associated	 with	 severe	 limitations	 to	 climb	 up	 stairs	
(Table	3).	Age,	BMI	and	type	3	VWD	were	independently	associated	
with	severe	limitations	to	bow,	to	kneel	or	to	bend	(Table	3).
TA B L E  3  Significant	associations	with	binomial	outcomes	in	
multivariate	logistic	regression	analysis
Variable Odds ratio
95% confidence 
interval P‐value
Sports	participation
Body	mass	index 0.96 0.93‐0.99 0.009
Participation	in	high‐risk	sports
Age 0.96 0.95‐0.98 <0.001
Female	sex 0.24 0.14‐0.39 <0.001
No	sports	participation	due	to	fear	of	bleeding
Age 1.05 1.01‐1.09 0.013
Type	3	VWD 13.24 2.45‐71.53 0.003
No	sports	participation	due	to	physical	limitations
Age 1.03 1.01‐1.05 0.002
Body	mass	index 1.10 1.03‐1.17 0.004
Type	3	VWD 5.90 1.77‐19.72 0.004
More	than	4	h	of	physical	activity	per	week
Body	mass	index 0.95 0.91‐0.98 0.001
Severe	limitations	to	walk	1000	m
Age 1.06 1.03‐1.08 <0.001
Female	sex 2.29 1.13‐4.63 0.021
Body	mass	index 1.14 1.08‐1.22 <0.001
Type	3	VWD 4.51 1.08‐18.92 0.039
Severe	limitations	to	lift	or	to	carry	groceries
Age 1.07 1.04‐1.09 <0.001
Female	sex 3.96 1.62‐9.72 0.003
Type	3	VWD 5.72 1.36‐24.05 0.017
Severe	limitations	to	climb	up	stairs
Age 1.05 1.03‐1.08 <0.001
Body	mass	index 1.13 1.06‐1.21 <0.001
Severe	limitations	to	bow,	to	kneel	or	to	bend
Age 1.06 1.03‐1.08 <0.001
Body	mass	index 1.14 1.07‐1.21 <0.001
Type	3	VWD 9.81 2.78‐34.57 <0.001
Outcomes	of	stepwise	multivariate	logistic	regression	analysis	using	the	
Wald	test	in	a	forward	approach.	The	determinants	that	were	included	in	
all	models	were	age,	sex,	body	mass	index	and	type	of	VWD.	Only	the	
determinants	 that	were	 significantly	associated	with	 the	binomial	out‐
comes	are	presented.
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3.5 | Physical activity, general health 
status and happiness
We	found	a	linear	association	between	more	hours	of	physical	activity	
per	week	and	a	better	general	health	status	(P	<	0.001).	For	instance,	
from	the	patients	who	did	more	than	4	hours	of	physical	activity	per	
week,	58	patients	(37.2%)	scored	their	health	status	as	very	good	or	ex‐
cellent,	whereas	in	patients	who	did	<1‐hour	physical	activity	per	week	
only	24	patients	(20%)	scored	their	health	status	as	very	good	or	excel‐
lent.	Moreover,	in	patients	who	did	more	than	4	hours	of	physical	ac‐
tivity	per	week,	only	20	patients	(12.8%)	scored	their	general	health	as	
moderate	or	bad,	whereas	in	patients	who	did	<1‐hour	physical	activity	
per	week	34	patients	(28.3%)	scored	their	health	status	as	moderate	or	
bad.	Additionally,	we	found	a	linear	association	between	more	hours	of	
physical	activity	per	week	and	how	happy	patients	felt	in	the	previous	
4	weeks	before	study	inclusion	(P	<	0.001).	Furthermore,	patients	who	
participated	in	sports	scored	their	health	status	better	(P	<	0.001)	and	
tended	to	feel	more	happy	the	previous	4	week	before	inclusion	in	the	
study	(P	=	0.082),	than	patients	who	did	not	participate	in	sports.
4  | DISCUSSION AND CONCLUSION
This	study	shows	that	although	a	large	proportion	of	VWD	patients	
participated	 in	 various	 types	 of	 sports,	 type	 3	 VWD	 patients	 are	
limited	 in	 sports	 participation	 in	 several	ways.	 Patients	with	 type	
3	VWD,	 a	more	 severe	bleeding	phenotype	 and	 a	 history	of	 joint	
bleeds	more	often	did	not	participate	 in	sports	because	of	 fear	of	
bleeding	or	because	of	physical	limitations.	Moreover,	these	patients	
frequently	had	severe	limitations	in	walking	distance	and	severe	limi‐
tations	during	daily	activities.	Lastly,	patients	who	did	more	physical	
activities	and	patients	who	participated	in	sports	scored	higher	on	
general	health	status	and	felt	more	happy	in	the	month	prior	to	study	
inclusion,	than	other	VWD	patients.
The	sports	participation	rate	in	VWD	patients	in	our	study	is	com‐
parable	to	the	general	sports	participation	rate	in	the	Netherlands.13 
In	 males	 ageing	 16‐55	years,	 the	 types	 of	 sports	 in	 which	 VWD	
patients	participated	were	very	comparable	to	the	types	of	sports	
in	the	general	population	(Figure	3).	Even	participation	in	a	high‐risk	
sport	 as	 soccer	 was	 comparable	 between	 VWD	 patients	 and	 the	
general	population.	This	is	 in	contrast	to	patients	with	severe	hae‐
mophilia,	who	participated	less	frequently	in	high‐risk	sports	such	as	
soccer,	while	they	more	often	participated	in	swimming	(Figure	3).13 
This	 is	 in	 line	with	 the	 recommendation	on	 sports	participation	 in	
haemophilia	patients,	as	recently	reviewed	by	Howell	et	al16
In	the	healthy	population	and	haemophilia	patients,	sports	par‐
ticipation	and	physical	activity	are	associated	with	a	better	quality	of	
life	and	may	reduce	the	frequency	of	spontaneous	bleeding	due	to	
improved	strength	and	fitness.16,23‐25	In	accordance,	we	also	found	
that	 VWD	 patients	 who	 participated	 in	 sports	 and	 patients	 who	
were	more	physically	active	scored	their	general	health	status	better	
and	 felt	more	happy,	 than	other	VWD	patients.	This	may	 indicate	
that	sports	participation	and	physical	activity	are	not	only	beneficial	
to	physical	health	 in	patients	with	bleeding	disorders,	but	also	 for	
mental	health.
Patients	who	did	not	participate	in	sports	due	to	fear	of	bleed‐
ing	or	physical	limitations	more	often	had	type	3	VWD	and	also	had	
a	more	 severe	bleeding	phenotype.	This	was	expected,	given	 the	
more	severe	bleeding	phenotype	in	patients	with	type	3	compared	
to	type	1	and	2	VWD.	In	our	population,	VWD	patients	with	physi‐
cal	limitations	experienced	more	severe	joint	bleeds	in	the	past.	In	a	
previous	study,	we	found	that	VWD	patients	with	joint	bleeds	in	the	
past	had	more	often	joint	damage	and	chronic	joint	pain	than	other	
VWD	patients.5,26	This	may	explain	why	these	patients	participated	
less	often	in	sports.	Furthermore,	women	with	menorrhagia	more	
often	did	not	participate	in	sports	due	to	physical	limitations.	This	
may	 indicate	 that	 in	 these	women,	menorrhagia	 has	 a	 significant	
role	on	their	social	activities.	It	is	important	for	patients	with	type	
3	VWD,	patients	with	a	high	bleeding	score	and	patients	with	joint	
bleeds	in	the	past,	to	be	informed	on	the	relevance	of	sports	partici‐
pation	and	possibilities	of	participating	in	sports	with	a	low	bleeding	
risk	 (such	as	 swimming),	 and	 to	 advise	 sports	 that	 fit	 their	 physi‐
cal	abilities.16,27	In	women	with	menorrhagia,	 it	 is	 important	to	be	
aware	of	the	possible	impact	of	menorrhagia	on	their	social	life.
F I G U R E  2  Proportion	of	VWD	
patients	with	severe	limitations	during	
daily	life.	Ns,	not	significant;	*P	<	0.05
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We	did	not	find	an	association	between	VWF	levels,	type	2	VWD	
and	sports	participation	or	physical	activity	(data	partly	not	shown).	
As	expected,	this	means	that	a	severe	bleeding	history	is	better	cor‐
related	with	sports	participation	and	physical	activity	than	VWF	lev‐
els.	Moreover,	it	indicates	that	only	the	most	severe	VWD	patients	
(ie,	type	3	VWD	and	patients	with	a	severe	bleeding	phenotype)	are	
limited	 in	 sports	 participation	 and	physical	 activity,	while	 patients	
with	a	moderate	bleeding	tendency	(type	2	VWD)	probably	experi‐
ence	less	limitations.
The	strength	of	this	study	is	that	it	is	the	first	study	to	investi‐
gate	sports	participation	and	physical	activity	of	VWD	patients.	We	
included	a	large	number	of	VWD	patients.	Therefore,	we	were	able	
to	compare	our	results	within	the	types	of	VWD.	We	also	compared	
our	findings	with	previous	reports	 in	haemophilia	patients	and	the	
general	population	 in	the	Netherlands.	Moreover,	we	were	able	to	
assess	the	association	between	sports	participation	and	physical	ac‐
tivity	and	the	bleeding	history	of	VWD	patients.
The	 primary	 limitation	 of	 this	 study	 is	 that	 we	 did	 not	 use	 a	
validated	physical	 activity	questionnaire.	However,	 the	questions	
that	 were	 asked	 about	 sports	 participation	 and	 physical	 activity	
per	week	were	similar	to	the	questionnaire	used	in	the	Hemophilia	
in	 the	Netherlands	 (HiN‐5)	 study.13	Moreover,	we	used	 validated	
SF‐36	questions	to	quantify	and	to	describe	physical	activity	during	
daily	 life.	 Secondly,	 the	 outcomes	 on	 sports	 participation	 and	
physical	 activity	 are	 patient‐reported.	 Since	 no	 clear	 definitions	
for	 sports	 and	physical	 activity	 exist,	 it	 is	 possible	 that	 a	 patient	
confused	these	terms.	Nevertheless,	there	is	no	reason	to	assume	
that	 the	 type	of	VWD	or	 the	bleeding	 risk	 is	associated	with	 the	
interpretation	 of	 the	 questions;	 therefore,	 it	 is	 unlikely	 that	 this	
potential	minor	deviancy	influenced	the	results.	Another	limitation	
of	this	study	is	that	we	did	not	have	detailed	information	on	how	
intense	or	frequent	sports	were	performed.	Lastly,	we	did	not	in‐
clude	a	control	group.
In	 conclusion,	 this	 is	 the	 first	 study	 on	 the	 physical	 activity	
and	sports	participation	of	patients	with	VWD.	In	general,	VWD	
patients	participate	as	frequent	and	 in	the	same	types	of	sports	
as	 the	general	population.	However,	patients	with	 type	3	VWD,	
a	more	severe	bleeding	phenotype,	and	a	history	of	 joint	bleeds	
participate	 less	 frequently	 in	 sports	 due	 to	 fear	 of	 bleeding	 or	
physical	 impairment.	 Moreover,	 these	 patients	 frequently	 have	
limitations	 in	 walking	 distance	 and	 in	 physical	 activities	 during	
daily	life.
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